Literature DB >> 35110708

Last-resort cancer therapy holds back disease for more than a decade.

Heidi Ledford.   

Abstract

Entities:  

Keywords:  Cancer; Immunology; Medical research; Synthetic biology

Mesh:

Year:  2022        PMID: 35110708     DOI: 10.1038/d41586-022-00241-0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

1.  CAR T cells produced in vivo to treat cardiac injury.

Authors:  István Tombácz; Amir Yadegari; Joel G Rurik; Pedro O Méndez Fernández; Swapnil V Shewale; Li Li; Toru Kimura; Ousamah Younoss Soliman; Tyler E Papp; Ying K Tam; Barbara L Mui; Steven M Albelda; Ellen Puré; Carl H June; Haig Aghajanian; Drew Weissman; Hamideh Parhiz; Jonathan A Epstein
Journal:  Science       Date:  2022-01-06       Impact factor: 47.728

2.  Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.

Authors:  J Joseph Melenhorst; Gregory M Chen; Meng Wang; David L Porter; Changya Chen; McKensie A Collins; Peng Gao; Shovik Bandyopadhyay; Hongxing Sun; Ziran Zhao; Stefan Lundh; Iulian Pruteanu-Malinici; Christopher L Nobles; Sayantan Maji; Noelle V Frey; Saar I Gill; Lifeng Tian; Irina Kulikovskaya; Minnal Gupta; David E Ambrose; Megan M Davis; Joseph A Fraietta; Jennifer L Brogdon; Regina M Young; Anne Chew; Bruce L Levine; Donald L Siegel; Cécile Alanio; E John Wherry; Frederic D Bushman; Simon F Lacey; Kai Tan; Carl H June
Journal:  Nature       Date:  2022-02-02       Impact factor: 69.504

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.